115 related articles for article (PubMed ID: 1472341)
1. Estimates of HIV infection among injecting drug users in Glasgow, 1985-1990.
Frischer M; Green ST; Goldberg DJ; Haw S; Bloor M; McKeganey N; Covell R; Taylor A; Gruer LD; Kennedy D
AIDS; 1992 Nov; 6(11):1371-5. PubMed ID: 1472341
[TBL] [Abstract][Full Text] [Related]
2. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus.
Davies AG; Cormack RM; Richardson AM
Int J Epidemiol; 1999 Feb; 28(1):117-21. PubMed ID: 10195675
[TBL] [Abstract][Full Text] [Related]
3. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group.
Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755
[TBL] [Abstract][Full Text] [Related]
4. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland.
Frischer M; Leyland A; Cormack R; Goldberg DJ; Bloor M; Green ST; Taylor A; Covell R; McKeganey N; Platt S
Am J Epidemiol; 1993 Aug; 138(3):170-81. PubMed ID: 8356960
[TBL] [Abstract][Full Text] [Related]
5. Low and stable prevalence of HIV among drug injectors in Glasgow.
Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L
Int J STD AIDS; 1994; 5(2):105-7. PubMed ID: 8031910
[TBL] [Abstract][Full Text] [Related]
6. Early mortality of undiagnosed but prevalent (in 1983-1984) HIV infection in Lothian injectors who tested hepatitis B surface antigen positive (group A) or negative but were high risk for blood-borne virus transmission (group B) in 1983-1984.
Gore SM; Brettle RP; Burns SM; Lewis SC
J Infect; 1998 Sep; 37(2):166-72. PubMed ID: 9821092
[TBL] [Abstract][Full Text] [Related]
7. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
[TBL] [Abstract][Full Text] [Related]
8. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow.
Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A
AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856
[TBL] [Abstract][Full Text] [Related]
9. HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.
Uusküla A; Raag M; Marsh K; Talu A; Vorobjov S; Des Jarlais D
PLoS One; 2017; 12(2):e0170956. PubMed ID: 28152026
[TBL] [Abstract][Full Text] [Related]
10. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
11. HIV testing and unreported HIV positivity among injecting drug users in London.
Donoghoe MC; Rhodes TJ; Hunter GM; Stimson GV
AIDS; 1993 Aug; 7(8):1105-11. PubMed ID: 8397948
[TBL] [Abstract][Full Text] [Related]
12. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
13. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
[TBL] [Abstract][Full Text] [Related]
14. Mortality among injecting drug users: a critical reappraisal.
Frischer M; Bloor M; Goldberg D; Clark J; Green S; McKeganey N
J Epidemiol Community Health; 1993 Feb; 47(1):59-63. PubMed ID: 8436897
[TBL] [Abstract][Full Text] [Related]
15. Female streetworking prostitution and HIV infection in Glasgow.
McKeganey N; Barnard M; Leyland A; Coote I; Follet E
BMJ; 1992 Oct; 305(6857):801-4. PubMed ID: 1422360
[TBL] [Abstract][Full Text] [Related]
16. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
17. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
[TBL] [Abstract][Full Text] [Related]
18. Distribution of HIV and acute hepatitis B infection among drug injectors in Glasgow.
Gruer LD; Peedle M; Carrington D; Clements GB; Follett EA
Int J STD AIDS; 1991; 2(5):356-8. PubMed ID: 1958720
[TBL] [Abstract][Full Text] [Related]
19. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
[TBL] [Abstract][Full Text] [Related]
20. HIV prevalence no higher among female drug injectors also involved in prostitution.
Rhodes T; Donoghoe M; Hunter G; Stimson GV
AIDS Care; 1994; 6(3):269-76. PubMed ID: 7948083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
